elucidating the first-line therapy approach for the managing acc
Published 1 year ago • 33 plays • Length 2:43Download video MP4
Download video MP3
Similar videos
-
1:12
elucidating the optimal second-line therapy in metastatic pancreatic cancer
-
2:55
state-of-the-art first-line therapy for mcrc
-
0:40
the importance of elucidating the right biomarkers in phase i oncology trials
-
2:02
elucidating the role of radiotherapy in treating brain metastases in breast cancer
-
1:12
asco gu 2023: moving immunotherapy into the first-line setting for bladder cancer
-
1:02
elucidating the biology of upper tract urothelial cancer
-
3:17
topaz-1: the addition of durvalumab to chemotherpay for the treatment of btc in the 1st-line setting
-
1:18
elucidating novel targets in nsclc
-
7:36
elekta: a united front against cancer
-
3:26
femtis comfort implantation & light focusing
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
1:25
developing clinical guidelines for the treatment of patients with thymic epithelial tumors
-
2:34
first-line treatments for patients with mhspc and mcrpc
-
2:21
first-line treatment decision making for patients with rcc
-
2:19
elucidating novel biomarkers for head and neck cancers
-
1:51
the evolving first-line treatment landscape for advanced rcc
-
4:23
first-line therapy options for rcc: lessons from checkmate 214 and keynote-427
-
1:22
the current treatment landscape and future directions of combination approaches for hcc
-
3:08
the management of oligometastatic and oligoremnant disease with local therapy
-
1:11
remaining questions for the treatment of patients with msi/dmmr mcrc with immunotherapy
-
1:54
the applications of ctdna in the management oligometastic disease
-
3:25
elucidating biomarkers of prognosis of 177lu-psma-617-based therapy